http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19980020006-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-48 |
| filingDate | 1996-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19980020006-A |
| titleOfInvention | Quinoline derivatives containing haloalkoxy groups and pharmaceutically acceptable salts thereof |
| abstract | The present invention relates to a quinoline derivative containing a new haloalkoxy group represented by the following structural formula (I), a pharmaceutically acceptable salt thereof, and a method for preparing the same.n n n [Formula 1]n n n (In formula (I), R 1 , R 2 , R 3 , R 4 and X are as defined in the specification.)n n n Since the quinoline derivative and its salt containing a haloalkoxy group have a function of inhibiting gastric acid secretion of a mammal, it can be usefully used as a therapeutic agent for gastric ulcer. |
| priorityDate | 1996-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.